Dyslipidemia is an emerging mechanism in microvascular complications in T2D. Elucidating the molecular pathomechanisms may pinpoint potential lipid-centric treatments. Interventional studies of dietary changes, exercise, or weight-loss surgery may also positively impact these highly prevalent and morbid complications.
No takes yet. Share an insight, caveat, or question.
Ross et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: